Timber Pharmaceuticals IncTimber Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

Other companies in the scoring peer group for Timber Pharmaceuticals Inc are shown below. Browse to the end of this webpage for potential risks for Timber Pharmaceuticals Inc based on industry, location and size. The page is a zero-cost E,S&G assessment covering Timber Pharmaceuticals Inc.

Timber Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.2; made up of an environmental score of 2.7, social score of 1.6 and governance score of 5.3.

SDG Transparency Score for Timber Pharmaceuticals Inc 

3.2

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Timber Pharmaceuticals Inc 
2.7

Environmental

1.6

Social

5.3

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
.........
1705Prothena Corporation PLC
3.3
Medium
1705Withus Pharmaceutical Co Ltd
3.3
Medium
1733Timber Pharmaceuticals Inc
3.2
Medium
1733AcuCort AB
3.2
Medium
1733Acura Pharmaceuticals Inc
3.2
Medium
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Timber Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc offer flexible work?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc disclose water use targets?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Timber Pharmaceuticals Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Timber Pharmaceuticals Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Timber Pharmaceuticals Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc disclose its waste policy?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc disclose energy use targets?

LockedSign up for free to unlock

Does Timber Pharmaceuticals Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Timber Pharmaceuticals Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Timber Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.

Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to severe subtypes of CI, a group of rare genetic keratinization disorders; and TMB-002, a proprietary topical formulation of rapamycin, which is in Phase 2b clinical trial for the treatment of facial angiofibroma in tuberous sclerosis complex, a multisystem genetic disorder resulting in the growth of hamartomas in multiple organs. It is also involved in the development of TMB-003, a proprietary formulation of Sitaxsentan, which is a selective endothelin-A receptor antagonist that is in preclinical development for the treatment of sclerotic skin diseases. In addition, the company engages in the development of BPX-01, which is in Phase 3 topical minocycline for the treatment of inflammatory lesions of acne vulgaris; and BPX-04 that is a Phase 3 ready topical minocycline for the treatment of papulopustular rosacea. It has license agreement with AFT Pharmaceuticals Limited. The company was founded in 2019 and is headquartered in Basking Ridge, New Jersey.

Sorry!

Failed to process!